|
Recent Newsletters
TAVR vs. SAVR in patients with pure AR | The state of nuclear cardiology | Leadless pacemakers for children |
Quality in outpatient ASCs | AI predicts common TAVR complication | Cardiologists react to FTC proposal |
New diet may lower diabetes risk | 4.2M Abbott devices recalled | HeartFlow raises $215M |
News Alert: FDA announces recall of 4.2M Abbott devices after hundreds of incidents, including multiple fires |
Heart Failure Highlights: New data from CVRx & Abbott | Key insights from ACC.23 | Tissue heads to space |
Multiple recalls | Key studies in interventional cardiology | AI bests humans | TAVR costs | More from the last week |
Drug recalled due to endocarditis risk | Intravascular imaging-guided PCI | Behind the scenes at a cardiac ASC |